• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM BR 27.29 (BR); SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM BR 27.29 (BR); SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR, Back to Search Results
Model Number N/A
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/17/2020
Event Type  malfunction  
Manufacturer Narrative
Siemens performed an internal correlation between atellica im br lot 047243/cg47 and lot 047245/cg47.Ten samples ranging from 16.45-176 u/ml were tested and the average percent bias observed was 2.73%.Siemens continues to investigate.
 
Event Description
The customer observed a bias between two lots of atellica im 1600 br 27.29 (br) reagents on six patient samples.There are no reports that treatment was altered or prescribed due to the bias between atellica 1600 br results.
 
Manufacturer Narrative
Siemens healthcare diagnostics filed initial mdr 1219913-2020-00171 on (b)(6) 2020.Additional information from (b)(6) 2020: poor patient correlation was observed with atellica im 1600 br 27.29 (br) between reagent lots 047243, and 047245.A correlation was performed by siemens, comparing br lot 047243/cg47 to br lot 047245/cg57.The average percent bias observed was 2.73%.The samples tested during the correlation are from throughout the assay range 16.45-176 u/ml.The samples used by the customer for their correlation were not from throughout the assay range,but ranged from 26.12-64.78 u/ml.The poor patient correlation results observed by the customer was not observed in siemens' internal testing.Siemens technical application specialist (tas) went to customer site and recalibrated with a new lot of reagent (lot 047249) and reran a patient correlation with acceptable results.Siemens is unable to rule out sample specific issue.Based on the investigation, no product problem was identified.The customer is operational.No further action is required.The result and conclusion codes have been updated to reflect the investigation results.Reference section h6 of this report for the updated codes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM BR 27.29 (BR)
Type of Device
SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR,
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown, ny
MDR Report Key10258139
MDR Text Key206379938
Report Number1219913-2020-00171
Device Sequence Number1
Product Code MOI
UDI-Device Identifier00630414598048
UDI-Public00630414598048
Combination Product (y/n)N
PMA/PMN Number
K982680
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 08/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/10/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/04/2020
Device Model NumberN/A
Device Catalogue Number10995477
Device Lot Number243
Was Device Available for Evaluation? No
Date Manufacturer Received07/30/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-